![]() ![]() A prime example of this is Bluegrass Vascular Technologies, a medical technology firm that received a De Novo classification from the FDA in 2020 for its Surfacer Inside-Out Access Catheter System. The growth of the central venous catheter market is expected to be propelled over the projected timeframe due to regulatory agencies issuing guidelines to market participants regarding catheter classification. It is projected that the global market for central venous catheter will reach a worth of US$ 2,117.8 million by 2021 and will demonstrate a CAGR of 6.2% from 2021 to 2028.ĭuring the projected timeframe, the global central venous catheter market is anticipated to experience growth as regulatory authorities provide guidance to industry participants on the categorization of these catheters. Furthermore, the elderly, who traditionally make up a significant portion of blood donors, were among the most vulnerable to the virus, resulting in reduced donations from this group. A published article in Transfusion Medicine and Hemotherapy in November 2021 revealed that the COVID-19 pandemic created additional obstacles for blood transfusion owing to the implementation of lockdown policies, social distancing requirements, and concerns about virus transmission through blood. The global central venous catheters market is expected to experience a setback due to the diminishing number of blood transfusions. Patients’ reluctance to continue treatment.Transportation disruptions caused by lockdown measures.Altered hospitalization policies caused by the pandemic.The study found that the patients had to modify or delay their chemotherapy regimens due to various factors, including: The study examined the impact of COVID-19’s emergence on stage II and stage III colon cancer patients undergoing adjuvant chemotherapy in China. ![]() An example of this can be seen in a study published in the Canadian Cancer Research Journal, Current Oncology, in June 2020. ![]() The global central venous catheters market is projected to experience a slowdown in growth during the forecast period due to the COVID-19 pandemic. Impact of the Coronavirus (COVID-19) Pandemic To Understand Business Strategies, Request For a Sample Report The guidelines cover essential aspects related to central venous catheters, including appropriate training for healthcare personnel responsible for catheter insertion, selecting the catheter application sites, and monitoring and surveilling staff. In 2011, the Centers for Disease Control and Prevention (CDC) issued guidelines aimed at preventing intravascular catheter-related infections, which were subsequently updated in 2017. Its primary use is for the administration of various fluids, including intravenous fluids, blood transfusions, and chemotherapy drugs, directly into a patient’s body. In addition, these catheters are used to measure Central Venous Pressure (CVP), hemodialysis, and chemotherapy over a long period of time.Ī flexible tube inserted into the vein below the right side of the collarbone and guided towards the superior vena cava, a large vein towards the heart, is commonly referred to as a central venous catheter, central line, or central venous line. The catheter reaches the large vein through the internal jugular vein, subclavian vein, or femoral vein to administer medicines, fluids, nutrients, blood, and blood products. A central venous catheter is also known as central line catheter, which has a long, thin, flexible tube that is placed in a large vein near the heart. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |